US Patent Number
The invention relates to a novel method of administering aspirin to achieve improved delivery thereof. The invention further relates to novel dosage forms of neutralized aspirin adapted for nasal administration, such as solutions, suspensions, gels and ointments. These dosage forms find utility in the treatment of conditions known to respond to the administration of aspirin, particularly in the treatment of migraine and in the mitigation of cardiovascular damage resulting from heart attack.
University of Kentucky Research Foundation, Lexington, Ky.
Hussain, Anwar A.; Dittert, Lewis W.; and Foster, Thomas S., "Novel Method of Administering Aspirin and Dosage Forms Containing Same" (1989). Pharmaceutical Sciences Faculty Patents. 154.